1. Home
  2. CNTN vs MRLN Comparison

CNTN vs MRLN Comparison

Compare CNTN & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

HOLD

Current Price

$1.95

Market Cap

178.5M

Sector

Health Care

ML Signal

HOLD

Logo Merlin Inc. Common Stock

MRLN

Merlin Inc. Common Stock

HOLD

Current Price

$1.12

Market Cap

172.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTN
MRLN
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
178.5M
172.8M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
CNTN
MRLN
Price
$1.95
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $7.92
AVG Volume (30 Days)
835.5K
★ 3.6M
Earning Date
11-11-2026
11-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.10
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.23
Revenue Next Year
N/A
$153.29
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$1.15
52 Week High
$5.27
$17.00

Technical Indicators

Market Signals
Indicator
CNTN
MRLN
Relative Strength Index (RSI) 38.49 23.77
Support Level $1.75 N/A
Resistance Level $2.40 $3.45
Average True Range (ATR) 0.16 0.15
MACD -0.05 -0.00
Stochastic Oscillator 0.59 0.00

Price Performance

Historical Comparison
CNTN
MRLN

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About MRLN Merlin Inc. Common Stock

Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.

Share on Social Networks: